Cargando…
Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry
[Image: see text] De novo drug design with desired biological activities is crucial for developing novel therapeutics for patients. The drug development process is time- and resource-consuming, and it has a low probability of success. Recent advances in machine learning and deep learning technology...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268960/ https://www.ncbi.nlm.nih.gov/pubmed/37171372 http://dx.doi.org/10.1021/acs.jcim.3c00562 |
_version_ | 1785059141231837184 |
---|---|
author | Kao, Po-Yu Yang, Ya-Chu Chiang, Wei-Yin Hsiao, Jen-Yueh Cao, Yudong Aliper, Alex Ren, Feng Aspuru-Guzik, Alán Zhavoronkov, Alex Hsieh, Min-Hsiu Lin, Yen-Chu |
author_facet | Kao, Po-Yu Yang, Ya-Chu Chiang, Wei-Yin Hsiao, Jen-Yueh Cao, Yudong Aliper, Alex Ren, Feng Aspuru-Guzik, Alán Zhavoronkov, Alex Hsieh, Min-Hsiu Lin, Yen-Chu |
author_sort | Kao, Po-Yu |
collection | PubMed |
description | [Image: see text] De novo drug design with desired biological activities is crucial for developing novel therapeutics for patients. The drug development process is time- and resource-consuming, and it has a low probability of success. Recent advances in machine learning and deep learning technology have reduced the time and cost of the discovery process and therefore, improved pharmaceutical research and development. In this paper, we explore the combination of two rapidly developing fields with lead candidate discovery in the drug development process. First, artificial intelligence has already been demonstrated to successfully accelerate conventional drug design approaches. Second, quantum computing has demonstrated promising potential in different applications, such as quantum chemistry, combinatorial optimizations, and machine learning. This article explores hybrid quantum-classical generative adversarial networks (GAN) for small molecule discovery. We substituted each element of GAN with a variational quantum circuit (VQC) and demonstrated the quantum advantages in the small drug discovery. Utilizing a VQC in the noise generator of a GAN to generate small molecules achieves better physicochemical properties and performance in the goal-directed benchmark than the classical counterpart. Moreover, we demonstrate the potential of a VQC with only tens of learnable parameters in the generator of GAN to generate small molecules. We also demonstrate the quantum advantage of a VQC in the discriminator of GAN. In this hybrid model, the number of learnable parameters is significantly less than the classical ones, and it can still generate valid molecules. The hybrid model with only tens of training parameters in the quantum discriminator outperforms the MLP-based one in terms of both generated molecule properties and the achieved KL divergence. However, the hybrid quantum-classical GANs still face challenges in generating unique and valid molecules compared to their classical counterparts. |
format | Online Article Text |
id | pubmed-10268960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-102689602023-06-16 Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry Kao, Po-Yu Yang, Ya-Chu Chiang, Wei-Yin Hsiao, Jen-Yueh Cao, Yudong Aliper, Alex Ren, Feng Aspuru-Guzik, Alán Zhavoronkov, Alex Hsieh, Min-Hsiu Lin, Yen-Chu J Chem Inf Model [Image: see text] De novo drug design with desired biological activities is crucial for developing novel therapeutics for patients. The drug development process is time- and resource-consuming, and it has a low probability of success. Recent advances in machine learning and deep learning technology have reduced the time and cost of the discovery process and therefore, improved pharmaceutical research and development. In this paper, we explore the combination of two rapidly developing fields with lead candidate discovery in the drug development process. First, artificial intelligence has already been demonstrated to successfully accelerate conventional drug design approaches. Second, quantum computing has demonstrated promising potential in different applications, such as quantum chemistry, combinatorial optimizations, and machine learning. This article explores hybrid quantum-classical generative adversarial networks (GAN) for small molecule discovery. We substituted each element of GAN with a variational quantum circuit (VQC) and demonstrated the quantum advantages in the small drug discovery. Utilizing a VQC in the noise generator of a GAN to generate small molecules achieves better physicochemical properties and performance in the goal-directed benchmark than the classical counterpart. Moreover, we demonstrate the potential of a VQC with only tens of learnable parameters in the generator of GAN to generate small molecules. We also demonstrate the quantum advantage of a VQC in the discriminator of GAN. In this hybrid model, the number of learnable parameters is significantly less than the classical ones, and it can still generate valid molecules. The hybrid model with only tens of training parameters in the quantum discriminator outperforms the MLP-based one in terms of both generated molecule properties and the achieved KL divergence. However, the hybrid quantum-classical GANs still face challenges in generating unique and valid molecules compared to their classical counterparts. American Chemical Society 2023-05-12 /pmc/articles/PMC10268960/ /pubmed/37171372 http://dx.doi.org/10.1021/acs.jcim.3c00562 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Kao, Po-Yu Yang, Ya-Chu Chiang, Wei-Yin Hsiao, Jen-Yueh Cao, Yudong Aliper, Alex Ren, Feng Aspuru-Guzik, Alán Zhavoronkov, Alex Hsieh, Min-Hsiu Lin, Yen-Chu Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry |
title | Exploring the Advantages
of Quantum Generative Adversarial
Networks in Generative Chemistry |
title_full | Exploring the Advantages
of Quantum Generative Adversarial
Networks in Generative Chemistry |
title_fullStr | Exploring the Advantages
of Quantum Generative Adversarial
Networks in Generative Chemistry |
title_full_unstemmed | Exploring the Advantages
of Quantum Generative Adversarial
Networks in Generative Chemistry |
title_short | Exploring the Advantages
of Quantum Generative Adversarial
Networks in Generative Chemistry |
title_sort | exploring the advantages
of quantum generative adversarial
networks in generative chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268960/ https://www.ncbi.nlm.nih.gov/pubmed/37171372 http://dx.doi.org/10.1021/acs.jcim.3c00562 |
work_keys_str_mv | AT kaopoyu exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry AT yangyachu exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry AT chiangweiyin exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry AT hsiaojenyueh exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry AT caoyudong exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry AT aliperalex exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry AT renfeng exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry AT aspuruguzikalan exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry AT zhavoronkovalex exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry AT hsiehminhsiu exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry AT linyenchu exploringtheadvantagesofquantumgenerativeadversarialnetworksingenerativechemistry |